MABVAX THERAPEUTICS HOLDINGS, INC. (NASDAQ:MBVX) Files An 8-K Financial Statements and ExhibitsItem 9.01
Financial Statements and Exhibits.
(d) The following exhibit is furnished as part of this Amended Current Report on Form 8-K:
Letter from CohnReznick LLP to the Securities and Exchange Commission, dated May 21, 2018.